This work was supported in part by the National Natural Science Foundation of China (Grant No. 39870879);the State "863" High-Tech Project (Grant Nos.102-08-04-01 and 2001AA215261); the Key Project from the Committee of Beijing Science Technology (Gra
To screen specific antitumor drugs targeting telomerase catalytic subunit (hEST2), 12 different hEST2 antisense oligonucleotides were designed based on hEST2 mRNA second structure and transfected into tumor cell lines...